(Q43592846)

25 November 2017

title

Association of the DRD2 and DRD3 polymorphisms with response to pramipexole in Parkinson's disease patients (English)

1 reference

25 November 2017

1 reference

Ying-Zi Liu

1

1 reference

25 November 2017

Bei-Sha Tang

2

1 reference

25 November 2017

Xin-Xiang Yan

3

1 reference

25 November 2017

Jie Liu

4

1 reference

25 November 2017

Dong-Sheng Ouyang

5

1 reference

25 November 2017

Li-Nuo Nie

6

1 reference

25 November 2017

Lan Fan

7

1 reference

25 November 2017

Zhi Li

8

1 reference

25 November 2017

Wei Ji

9

1 reference

25 November 2017

Dong-Li Hu

10

1 reference

25 November 2017

Dan Wang

11

1 reference

25 November 2017

Hong-Hao Zhou

12

1 reference

25 November 2017

publication date

25 April 2009

1 reference

European Journal of Clinical Pharmacology

25 November 2017

published in

1 reference

25 November 2017

volume

65

1 reference

25 November 2017

issue

7

1 reference

25 November 2017

page(s)

679-683

1 reference

https://scigraph.springernature.com/pub.10.1007/s00228-009-0658-z

25 November 2017

exact match

0 references

cites work

Association study of dopamine D2, D3 receptor gene polymorphisms with motor fluctuations in PD

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00228-009-0658-Z

Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers

21 January 2018

1 reference

12 December 2020

Genotypes of catechol-O-methyltransferase and response to levodopa treatment in patients with Parkinson's disease

1 reference

12 December 2020

Dopamine D3 receptor gene polymorphism and violent behavior: relation to impulsiveness and ADHD-related psychopathology

1 reference

12 December 2020

Dopamine agonist monotherapy in Parkinson's disease

1 reference

12 December 2020

Pharmacogenetics of antiparkinsonian drug treatment: a systematic review.

1 reference

12 December 2020

Proposed schizophrenia-related gene polymorphism: expression of the Ser9Gly mutant human dopamine D3 receptor with the Semliki Forest virus system

1 reference

12 December 2020

Polymorphisms in candidate genes: implications for the current treatment of Parkinson's disease

1 reference

12 December 2020

Difference in erythrocyte catechol-O-methyltransferase activity between Orientals and Caucasians: difference in levodopa tolerance

1 reference

12 December 2020

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

1 reference

12 December 2020

1 reference

12 December 2020

The effect of monoamine oxidase B (MAOB) and catechol-O-methyltransferase (COMT) polymorphisms on levodopa therapy in patients with sporadic Parkinson's disease

1 reference

12 December 2020

CYP2D6 and DRD2 genes differentially impact pharmacodynamic sensitivity and time course of prolactin response to perphenazine

1 reference

12 December 2020

Dopamine transporter gene polymorphism, spect imaging, and levodopa response in patients with Parkinson disease

1 reference

12 December 2020

Catechol-O-methyltransferase activity: a determinant of levodopa response.

1 reference

12 December 2020

A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice

1 reference

12 December 2020

Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1

1 reference

12 December 2020

10.1007/S00228-009-0658-Z

Identifiers

DOI

1 reference

25 November 2017

1 reference